The HLTH 2023 conference served as a fruitful platform for discussions on the state of investment in digital health markets, as outlined by a variety of industry experts during a panel discussion entitled “The Great Leveling Out”. The panel was moderated by Sofia Guerra from Bessemer Venture Partners and highlighted insights into attitudes and strategies among investors navigating this ever-evolving sector.
The panel comprised industry veterans at different stages in the investment spectrum. Laura Veroneau, Managing Director of Optum Ventures, represented the point of view of those involved in early-stage financing. Her insights offered a glimpse into the unique challenges and rewards inherent in backing businesses at their genesis, a stage characterized by innovative disruptions in digital health.
From the perspective of mature private equity (PE) financing, Andrew Adams, Managing Director of Oak HC/FT, brought to light the distinct nuances of contributing to health-tech companies that have already carved out a substantial foothold in the market. His observations emphasize how companies at this stage of financial maturity can provide steady growth and stable investment opportunities.
Lastly, in the realm of public strategic buyers, the panel received input from Nick Richtt, Managing Director of JPMorgan. Evaluating the current state of digital health markets from the purview of large-scale, strategic buying allows for an understanding of how these market dynamics are influenced by such transactions, contributing to a broader understanding of the ecosystem.
Each of these panelists’ observations and insights contribute to a more robust evaluation of the digital health market from investment point of view, shedding light not only on current trends but also potential future shifts.
For a more detailed account of the panel’s discussion, visit the original article on JD Supra.